Locations:
SearchAccess focus respects patient anxiety and fear
The time it takes for a person to receive their first therapy after diagnosis is a surrogate marker for the amount of empathy in a culture, says Chair of Physician Leadership and Development and former Chair of Taussig Cancer Institute Brian Bolwell, MD, FACP. It demonstrates respect for the level of anxiety and fear a cancer diagnosis can produce. It also cascades to other metrics required by the U.S. Department of Health and Human Services Agency for Healthcare Research and Quality.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Hear why Dr. Bolwell keeps pushing for progress in time to treat:
Dr. Bolwell is Chair of Physician Leadership and Development and former Chair of Taussig Cancer Institute. He can be reached at bolwelb@ccf.org or 216.444.6922. On Twitter: @BrianBolwellMD
Advertisement
Advertisement
Timing and type of side effects differ greatly from chemotherapy
Dedicated multidisciplinary teams support 84 ultra-rare cancers
Sessions explore treatment advances and multidisciplinary care
New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues
Combination of olaparib and carboplatin results in complete durable response for a patient with BRCA2 and “BRCAness” mutations
Early communication between oncologists and ophthalmologist warranted
Case-based course delves into latest treatment approaches
Long-term relationship building and engagement key to gaining community trust